Randomized trial · people

Thymosin Beta-4: no serious adverse events in healthy volunteers

Checked against the paper Randomized trialPublished by PepVault

The takeaway

This is the first human safety data for lab-made thymosin beta-4 given into a vein. It was well tolerated in healthy volunteers, but this study says nothing about benefit.

Kind
Randomized trial
Studied in
People
Published
2021
Journal
J Cell Mol Med

What they tested

The team tested whether a lab-made version of human thymosin beta-4, called NL005, is safe and tolerable when given into a vein, and how it moves through the body.

How the study was done

A randomized, double-blind phase I trial in healthy Chinese volunteers. In the single-dose part, 54 people in seven cohorts got one dose (0.05 to 25.0 μg/kg) or placebo, a dummy treatment, and were followed for 28 days. In the multiple-dose part, 30 people in three cohorts (0.5, 2.0 and 5.0 μg/kg) got a dose once a day for 10 days and were followed for 28 days.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Thymosin Beta-4? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Side effects were mild to moderate. No dose caused dose-limiting toxicity, meaning side effects severe enough to stop raising the dose, and there were no serious adverse events. Blood levels, including Cmax (the peak level) and AUC (total exposure over time), rose as the dose went up. Clearance from the body looked similar across doses, and the drug did not clearly build up after 10 daily doses.

What it doesn’t show

This was an early safety study in healthy people, so it did not test whether the drug treats any condition. It used only doses given into a vein, in small cohorts followed for 28 days.

The paper

Wang et al. A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers. J Cell Mol Med. 2021.

The compound

More studies on Thymosin Beta-4

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Thymosin Beta-4? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo